 |
|
|
|
|
|
|
|
 |
|
||||||
 |
 |
 |
 |
 |
 |
 |
|
Analyst Conference Summaries
Dicerna Pharmaceuticals
DRNA
conference date: November 9, 2021 @ 5:30 AM Pacific Time
Dicerna to be Acquired by Novo Nordisk
Dicerna Pharmaceuticals May Be the Best Value Among RNAi Companies [September 15, 2020 at Seeking Alpha]
Dicerna: An RNA Therapy-Based 21st Century Likely Winner [July 12, 2019 at Seeking Alpha]
| 2021 | |||
| Dicerna (DRNA) Q1 2021 |
Dicerna (DRNA) Q2 2021 |
Dicerna (DRNA) Q3 2021 |
|
| May 6, 2021 | Aug. 9, 2021 | Nov. 9, 2021 | |
| 2020 | |||
| Dicerna (DRNA) Q1 2020 |
Dicerna (DRNA) Q2 2020 |
Dicerna (DRNA) Q3 2020 |
Dicerna (DRNA) Q4 2020 |
| May 7, 2020 | Aug. 6, 2020 | Nov. 5, 2020 | Feb. 25, 2021 |
| 2019 | |||
| Dicerna (DRNA) Q2 2019 |
Dicerna (DRNA) Q3 2019 |
Dicerna (DRNA) Q4 2019 |
|
| Aug. 8, 2019 | Nov. 7, 2019 | Feb. 27, 2020 | |
Dicerna Pharmaceuticals (DRNA) is a clinical-stage biotechnology company specializing in RNA therapies for genetic diseases.
Dicerna Pharmaceuticals web site
I bought my first DRNA on September 14, 2020. I sold mine on the acquisition announcement on 11/18/2021
More Analyst Conference Pages:
| AGEN |
| AGIO |
| ALNY |
| ALXN |
| AMAT |
| AMGN |
| APRE |
| ARWR |
| BIIB |
| BMY |
| CLDX |
| CLSN |
| EPZM |
| GILD |
| GLYC |
| ILMN |
| INO |
| IONS |
| ISRG |
| MCHP |
| MRNA |
| PLX |
| RETA |
| REGN |
| RNA |
| SAGE |
| SGEN |
| SYRS |
| TTPH |
| VBLT |
| VSTM |
| WBA |
Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.
Copyright 2021 William P. Meyers